Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors
- PMID: 7777184
- DOI: 10.1016/0304-3940(95)11306-h
Differential effects of [3H]nemonapride and [3H]spiperone binding on human dopamine D4 receptors
Abstract
We compared some binding parameters of [3H]nemonapride and [3H]spiperone in human dopamine D4 (hD4) receptors with three different numbers of tandem repeat units. Although both of the radioligands showed similar affinity constants for each hD4 receptor variant, the maximal number of binding sites labeled by [3H]nemonapride was approximately 1.35-fold higher than that by [3H]-spiperone for all variants. Estimated Ki values for the inhibition of [3H]nemonapride binding by a series of dopaminergic ligands were highly correlated to respective values obtained for the inhibition of [3H]spiperone binding to each hD4 receptor. These results suggest that the hD4 receptor, as shown for the D2 receptor, may exist in multiple molecular forms as a monomer-dimer equilibria, and that [3H]spiperone may discriminate in the multiple molecular forms.
Similar articles
-
[3H]nemonapride and [3H]spiperone label equivalent numbers of D2 and D3 dopamine receptors in a range of tissues and under different conditions.J Neurochem. 1995 Feb;64(2):940-3. doi: 10.1046/j.1471-4159.1995.64020940.x. J Neurochem. 1995. PMID: 7830089
-
(-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.Eur J Pharmacol. 2001 Dec 7;432(2-3):143-7. doi: 10.1016/s0014-2999(01)01484-4. Eur J Pharmacol. 2001. PMID: 11740949
-
Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.Biochem Biophys Res Commun. 1999 Feb 16;255(2):367-70. doi: 10.1006/bbrc.1999.0220. Biochem Biophys Res Commun. 1999. PMID: 10049714
-
Dopamine D4 receptors: curiouser and curiouser.Trends Pharmacol Sci. 1994 Sep;15(9):317-9. doi: 10.1016/0165-6147(94)90020-5. Trends Pharmacol Sci. 1994. PMID: 7992381 Review. No abstract available.
-
Recent findings leading to the discovery of selective dopamine D4 receptor ligands for the treatment of widespread diseases.Eur J Med Chem. 2021 Feb 15;212:113141. doi: 10.1016/j.ejmech.2020.113141. Epub 2020 Dec 29. Eur J Med Chem. 2021. PMID: 33422983 Review.
Cited by
-
The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.Br J Pharmacol. 2013 Dec;170(8):1459-581. doi: 10.1111/bph.12445. Br J Pharmacol. 2013. PMID: 24517644 Free PMC article.
-
In vitro pharmacological profile of YM-43611, a novel D2-like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors.Br J Pharmacol. 1996 Apr;117(8):1625-32. doi: 10.1111/j.1476-5381.1996.tb15332.x. Br J Pharmacol. 1996. PMID: 8732269 Free PMC article.
-
Crystal structure of dopamine receptor D4 bound to the subtype selective ligand, L745870.Elife. 2019 Nov 21;8:e48822. doi: 10.7554/eLife.48822. Elife. 2019. PMID: 31750832 Free PMC article.
-
A Complete Assessment of Dopamine Receptor- Ligand Interactions through Computational Methods.Molecules. 2019 Mar 27;24(7):1196. doi: 10.3390/molecules24071196. Molecules. 2019. PMID: 30934701 Free PMC article.
-
The importance of dopamine D4 receptors in the action and development of antipsychotic agents.Drugs. 1996 Jan;51(1):7-11. doi: 10.2165/00003495-199651010-00002. Drugs. 1996. PMID: 8741229 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases